Lexology August 14, 2023
This week marks the one-year anniversary since the enactment of the Inflation Reduction Act (IRA), which included sweeping reforms empowering the Secretary of Health and Human Services (HHS) to set prices for certain pharmaceuticals in the Medicare program. Since enactment last year, the Biden-Harris administration has repeatedly made it clear that they are full-steam ahead with implementing the law’s drug pricing provisions and have even proposed doubling down on them in their Fiscal Year 2024 Budget Proposal with plans to increase the scope of the program. As the IRA marks its one-year anniversary and stakeholders prepare for key implementation milestones in the weeks and months ahead, this client alert identifies key dates and complex and controversial aspects of IRA implementation...
Today's Sponsors
Today's Sponsor